Breast cancer
Results
Phase 1
This study looked at taselisib and palbociclib for breast cancer when other treatments have stopped working.
It was only for women with a change in a gene called PIK3CA.
This trial was open for people to join between 2015 and 2018. The team published the results in 2021.
Recruitment start: 27 February 2015
Recruitment end: 31 October 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nick Turner
Experimental Cancer Medicine Centre (ECMC)
Institute of Cancer Research (ICR)
Pfizer
Roche
The Royal Marsden NHS Foundation Trust
The Christie NHS Foundation Trust
Beatson Institute for Cancer Research
Last reviewed: 11 Aug 2022
CRUK internal database number: 14045
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
